PMV Pharmaceuticals, Inc. (PMVP) Reports In-Line Q3 EPS

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q3 EPS of ($0.40), in-line with the analyst estimate of ($0.40).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
• Tencent Music Entertainment Group (TME) PT Lowered to $9.50 at UBS
• Rapid7 (RPD) PT Raised to $14 at Canaccord